Physician profile
Risa Curtis
NPI 1952691438
$2,179.96
in general payments reported to CMS, 2019-2025
19 companies · $27.76 in 2025
The $27.76 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.64 · 2021: $677 · 2022: $488 · 2023: $266 · 2024: $682 · 2025: $27.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $466.03 | 2022-2024 | Descovy |
| Viiv Healthcare Company | $387.12 | 2022-2024 | Dovato, Apretude, Rukobia |
| Abbvie INC. | $370.83 | 2021-2025 | Qulipta, Vraylar |
| Exeltis, USA INC. | $170.32 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $138.92 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $96.31 | 2023-2024 | Pifeltro, Delstrigo |
| Hologic Sales and Service, LLC | $91.13 | 2022-2023 | Aptima |
| Myovant Sciences INC. | $89.01 | 2021-2022 | |
| Agile Therapeutics, INC. | $78.74 | 2021-2022 | |
| Evofem Biosciences, INC. | $67.29 | 2021-2022 | |
| Organon LLC | $43.40 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.07 | 2022 | |
| Antares Pharma, INC. | $34.17 | 2022 | |
| Emd Serono, INC. | $25.58 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.62 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $17.69 | 2021 | |
| Abbott Laboratories | $16.65 | 2023 | Proclaim |
| Avion Pharmaceuticals | $14.76 | 2022 | |
| Astellas Pharma US INC | $14.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Risa Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.